Hasibe Vural

6PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Plant pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 17, 2025
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson's Disease, Both In Vivo and In Vitro.

Ebru Guclu, Salim Yalcin Inan, Canan Eroglu Gunes

|Apr 11, 2025
A sesquiterpene lactone, tomentosin, as a novel anticancer agent: orchestrating apoptosis, autophagy, and ER stress in colorectal cancer.

Sümeyra Çetinkaya, Ebru Güçlü, İlknur Çınar Ayan

|Jul 15, 2024
Piceatannol induces caspase-dependent apoptosis by modulating intracellular reactive oxygen species/mitochondrial membrane potential and enhances autophagy in neuroblastoma cells.

Ebru Güçlü, İlknur Çınar Ayan, Sümeyra Çetinkaya

|May 16, 2024
Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.

Safaa Altves, Ebru Guclu, Esra Yetisgin

|Oct 03, 2023
Lysates from the probiotic bacterium Streptococcus thermophilus enhances the survival of T cells and triggers programmed cell death in neuroblastoma cells.

Safaa Altves, Ebru Guclu, Ilknur Cinar Ayan

|Oct 19, 2022
Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediated mitochondrial dysfunction in pancreatic cancer cells.

İlknur Çınar Ayan, Ebru Güçlü, Hasibe Vural

Pageof 1

Frequent Collaborators

6 joint publications

Ebru Güçlü

4 joint publications

İlknur Çınar Ayan

3 joint publications

Hatice Gül Dursun

2 joint publications

Safaa Altves